Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Douglas Warner, MD
EFFECTOR Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Southern California
Los Angeles, California, United States
Anthony El-Khoueiry, MDRecruiting - Valkyrie Clinical Trials
Los Angeles, California, United States
David Berz, MDRecruiting - Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
Completed - Stanford University
Palo Alto, California, United States
Jennifer Caswell-Jin, MDRecruiting - Start Midwest
Grand Rapids, Michigan, United States
Manish Sharma, MDRecruiting - Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
Completed - Memorial Sloan Kettering Cancer Center- Monmouth
Middletown, New Jersey, United States
Ezra Rosen, MDRecruiting - Memorial Sloan Kettering Cancer Center- Commack
Commack, New York, United States
Ezra Rosen, MDRecruiting - Memorial Sloan Kettering Cancer Center- Westchester
Harrison, New York, United States
Ezra Rosen, MDRecruiting - Memorial Sloan Kettering Cancer Center- David H. Koch Center for Cancer Care
New York, New York, United States
Ezra Rosen, MDRecruiting - University of Toledo Medical Center
Toledo, Ohio, United States
Completed - Md Anderson Cancer Center
Houston, Texas, United States
Funda Meric-Bernstam, MDRecruiting - New Experimental Therapeutics of San Antonio - Next Oncology
San Antonio, Texas, United States
Completed - Virginia Cancer Specialists
Fairfax, Virginia, United States
Alexander Spira, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Oct 2019
- Primary completion
- 31 Dec 2024
- Completion
- 31 Mar 2025
- Last update posted
- 21 May 2024
- Registered enrollment
- 30
- Registry id
- NCT04092673
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.